ACIP Live Meeting Archive - June 2013
June 19-20, 2013
Meeting Agenda June 19-20, 2013 [2 pages]
Videos: June 19, 2013 (Day 1)
- Welcome & Introductions [40:10 minutes]
- Opening Remarks
Dr. J Temte
Dr. L Pickering
- Opening Remarks
- Japanese Encephalitis [97:00 minutes]
- Introduction
Dr. J Bocchini
- Safety and immunogenicity of JE-VC in children
Dr. K Dubischar-Kastner
- GRADE evidence for JE-VC in children, Recommendations for use
Dr. M Fischer
- Introduction
- General Recommendations on Immunization [33:38 minutes]
- Overview
Dr. J Duchin - Preventing and managing adverse reactions
Dr. A Kroger
- Overview
- Pertussis Vaccines [140:44 minutes]
- Introduction
Dr. M Sawyer - Pertussis in the United States and Tdap vaccine effectiveness
Dr. A Acosta - Tdap revaccination: safety and immunogenicity
Dr. J Liang - Decision and cost effectiveness analysis: a second dose of Tdap
Dr. M. Messonnier, Dr. H Kamiya - Work group conclusions on a second dose of Tdap
Dr. J Liang - Maternal Tdap and cocooning: experiences from Australia and the United Kingdom
Dr. P McIntyre, Dr. D Salisbury
- Introduction
- Human Papillomavirus (HPV) Vaccines [85:12 minutes]
- Introduction
Dr. J Bocchini - Merck pregnancy registry for quadrivalent HPV vaccine
Dr. F Lievano - Plans for updated ACIP statement
Dr. E Dunne - HPV vaccine program and impact monitoring
Dr. L Markowitz
- Introduction
Videos: June 20, 2013 (Day 2)
- Rotavirus Vaccines: Update on Intussusception [142:24 minutes]
- Introduction: intussusception following RV5 and RV1
Dr. M Vázquez - VSD
Mr. E Weintraub - VAERS
Ms. P Haber - PRISM
Dr. K Yih - Australian data
Dr. P McIntyre - Summary and review of risk: benefit in the United States
Dr. M Cortese
- Introduction: intussusception following RV5 and RV1
- Role of Retail Pharmacies in Vaccine Delivery [59:22 minutes]
- The role of retail pharmacies/pharmacists in vaccine delivery in the United States
Mr. M Rothholz
- The role of retail pharmacies/pharmacists in vaccine delivery in the United States
- Herpes Zoster Vaccine [03:29 minutes]
- Update on Herpes Zoster Work Group activities
Dr. J Duchin
- Update on Herpes Zoster Work Group activities
- Influenza [131:15 minutes]
- Introduction
Dr. W Keitel - Epidemiology/surveillance update
Dr. L Finelli - H7N9 update
Dr. D Jernigan - Preliminary data on 2012-2013 vaccine effectiveness
Dr. M Thompson - Vaccine safety update
Dr. T Shimabukuro - FluLaval Quadrivalent: GSK’s inactivated quadrivalent seasonal influenza vaccine manufactured in Quebec
Dr. V Jain - 2013-2013 recommendations
Dr. L Grohskopf
- Introduction
No hay comentarios:
Publicar un comentario